Oppenheimer Initiates Coverage on MAKO Surgical with Perform Rating

In a report released earlier today, Oppenheimer Holdings announced it is initiating coverage of MAKO Surgical Corp. MAKO with a Perform rating, but did not set a price target. Oppenheimer went on to say in the report “With its robotically-assisted system, MAKO is leading the joint-reconstruction market into a new era of techniques to further improve outcomes of knee and hip replacement procedures. Our rating is largely valuation-based. At 12-13x '12E EVsales, the shares, we believe, reflect the near-term excitement over MAKO's strong partial knee replacement performance and the rollout of its new hip application.” MAKO Surgical Corp. closed at $41.19 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorInitiationAnalyst RatingsHealth CareHealth Care EquipmentOppenheimer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!